ID   Senju-CCS
AC   CVCL_E2TM
RX   PubMed=28745431;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=28745431).
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
RX   PubMed=28745431; DOI=10.1002/cam4.1130; PMCID=PMC5603837;
RA   Nakai T., Imura Y., Tamiya H., Yamada S., Nakai S., Yasuda N., Kaneko K.,
RA   Outani H., Takenaka S., Hamada K., Myoui A., Araki N., Ueda T., Itoh K.,
RA   Yoshikawa H., Naka N.;
RT   "Trabectedin is a promising antitumor agent potentially inducing
RT   melanocytic differentiation for clear cell sarcoma.";
RL   Cancer Med. 6:2121-2130(2017).
//